Brand
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
4 federal recalls on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. and translate it into plain English — free weekly digest, optional same-day alerts.
- 2024-05-01FDA-DrugClass IIIAbilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-011-13
Cross Contamination with Other Products
- 2024-05-01FDA-DrugClass IIIAbilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-009-13
Cross Contamination with Other Products
- 2024-05-01FDA-DrugClass IIIAbilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (NDC 59148-008-95), RX only, Otsuka America Pharmaceutical, Inc.
Cross Contamination with Other Products
- 2024-05-01FDA-DrugClass IIIAbilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-007-13
Cross Contamination with Other Products
Get notified about new Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. recalls
Free weekly digest. We email when a new federal recall affects Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. or anything else in your household.
Get the Sunday Brief